Patients with pre-existing gastroparesis, significant gastrointestinal disease, or previous gastric surgery require particularly careful monitoring and may benefit from gastroenterology consultation before initiating GLP-1 agonist therapy
Tirzepatide : Combines GLP-1 activity with another hormone, GIP (glucose-dependent insulinotropic polypeptide), enhancing its effects on appetite suppression and metabolic health
Many individuals consider BPC-157 + TB500 to assist with recovery from training strain, support joint and tendon function, and encourage overall structural wellness
Patients can lose 10% to 18% of their body weight and 20% to 25% with some of the newer medications, according to Dr
While opinions vary, patterns emerge over time, helping prospective players set realistic expectations